1910 Taubman Center 1500 E. Medical Center Drive
Ann Arbor, MI 48109
Available to mentor
Dr. Christopher Bichakjian is a professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School.
Dr. Bichakjian is a foremost expert in the field of cutaneous surgery and oncology. He has a special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006. He has presented over 100 national and international invited lectures and visiting professorships, and authored or co-authored nearly 90 peer-reviewed publications with a primary focus on cutaneous oncology.
Dr. Bichakjian received his medical degree from Radboud University in The Netherlands. After relocating to the US, he completed residency in dermatology and a fellowship in micrographic surgery and cutaneous oncology at Michigan Medicine. He subsequently practiced Mohs surgery in private practice and served as adjunct faculty at Weill Medical College at Cornell University in New York City.
In 2004, Dr. Bichakjian was recruited back to Ann Arbor to join the faculty in the Department of Dermatology at Michigan Medicine. He served as director of the UM Multidisciplinary Merkel Cell Carcinoma Program for more than a decade (2006-2017), In addition, he served as chief of the Division of Cutaneous Surgery and Oncology and as director of the Multidisciplinary Melanoma Program in the Rogel Cancer Center from 2017-2020.
On a national level, Dr. Bichakjian has been heavily involved with the American Joint Committee on Cancer (AJCC), the National Comprehensive Cancer Network (NCCN), and the American Academy of Dermatology (AAD) to improve and develop optimal staging and clinical practice guidelines in cutaneous oncology, for which he was awarded the AAD Presidential Citation Award in 2018. Dr. Bichakjian is past-president of the Michigan Dermatological Society and currently serves a nine-year term on the Board of Directors of the American Board of Dermatology.
-
Swetter SM, Johnson D, Albertini MR, Barker CA, Bateni S, Baumgartner J, Bhatia S, Bichakjian C, Boland G, Chandra S, Chmielowski B, DiMaio D, Dronca R, Fields RC, Fleming MD, Galan A, Guild S, Hyngstrom J, Karakousis G, Kendra K, Kiuru M, Lange JR, Lanning R, Logan T, Olson D, Olszanski AJ, Ott PA, Ross MI, Rothermel L, Salama AK, Sharma R, Skitzki J, Smith E, Tsai K, Wuthrick E, Xing Y, McMillian N, Espinosa S. J Natl Compr Canc Netw, 2024 Jul; 22 (5): 290 - 298.Journal ArticleNCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.
DOI:10.6004/jnccn.2024.0036 PMID: 39019054 -
Bichakjian C. 2024 May 2;PresentationUpdates in Melanoma and High-Risk SCC
-
2024 Mar 8;PresentationTranslating Evidence into Practice: Primary Cutaneous Melanoma Guidelines - Sentinel Lymph Node Biopsy Updates
-
Bichakjian C. 2023 Jul 4;PresentationKeratinocyte carcinomas - Basal cell carcinomas: De-intensification of treatment
-
Bichakjian C. 2023 Jun 28;PresentationDermatology and Mohs Micrographic Surgery at Michigan Medicine
-
2023 May 7;PresentationManaging Melanoma Risk and Prognosis by Gene Expression Profiling and Nodal Staging
-
2023 Apr 22;PresentationDermatology Day
-
2023 Mar 19;PresentationControversies in Dermatology: Mohs Micrographic Surgery as a treatment for melanoma